Help Direct Us In Our Future Prostate Cancer Support and Advocacy Actions
Please complete this ten minute, four question, anonymous survey about your thoughts around prostate cancer support and advocacy. Click>>> https://www.surveymonkey.com/s/CCRNTQP Your answers will help us to plan future prostate cancer support and advocacy actions on [...]
Developing a New Prognostic Model for in Men with First Line Chemotherapy
Current Prognostic models for overall survival (OS) for men with metastatic castration-resistant prostate cancer (mCRPC) have become dated. They don’t adequately reflect the many new drugs used in clinical practice. To develop a relevant model data from [...]
Malecare Adds A New Teleconference About Immunotherapy and Advanced Prostate Cancer
Malecare announces the addition of our latest and informative teleconference about Immunotherapy and Advanced Prostate Cancer. Joining me in the conference is Dr. Nicholas J. Vogelzang, M.D., a medical oncologist with the Comprehensive Cancer Centers of Nevada [...]
Cancer Depression – No Denying It Haunts Us All
We all are subject to developing depression and prostate cancer survivors are subject to a large share of it. Besides dealing with the everyday issues of living our life, we also are hounded by our [...]
Denosumab or Zoledronic Acid – Which is Superior for Pain Interference and Improving Quality of Life?
Men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) will often have debilitating pain that impacts every aspect of their daily functioning thus significantly diminishing their quality of life (QoL). Finding the best drug [...]
Understanding What Are Circulating Tumor Cells And What Is Their Role In Prostate Cancer Treatment
Circulating tumor cells (CTCs) is an area we will continue to hear more about as their importance to our understanding prostate cancer continues to increase. CTCs show the movement of cancer cells though the body. [...]